We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+9.08%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$19.9B
AUM Growth
+$675M
Cap. Flow
-$801M
Cap. Flow %
-4.02%
Top 10 Hldgs %
22.74%
Holding
1,397
New
101
Increased
520
Reduced
573
Closed
56

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$78.4M
2
CDNS icon
Cadence Design Systems
CDNS
+$67.2M
3
BBY icon
Best Buy
BBY
+$49.5M
4
HUM icon
Humana
HUM
+$40.2M
5
LEN icon
Lennar Class A
LEN
+$38.4M

Sector Composition

Rank Sector Weight
1 Technology 22.05%
2 Healthcare 11.68%
3 Financials 10.25%
4 Consumer Discretionary 9.33%
5 Industrials 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUE icon
351
Nucor
NUE
$58.3B
$11.1M 0.06%
55,940
-3,661
-6% -$669K
CASY icon
352
Casey's General Stores
CASY
$32.1B
$10.8M 0.05%
33,805
-12,476
-27% -$3.64M
MLAB icon
353
Mesa Laboratories
MLAB
$551M
$10.8M 0.05%
98,073
+7,190
+8% +$724K
CUBE icon
354
CubeSmart
CUBE
$9.61B
$10.7M 0.05%
236,488
+22,291
+10% +$988K
PCRX icon
355
Pacira BioSciences
PCRX
$1.04B
$10.6M 0.05%
363,405
+26,414
+8% +$811K
AEO icon
356
American Eagle Outfitters
AEO
$2.94B
$10.5M 0.05%
+408,449
New +$9.07M
POR icon
357
Portland General Electric
POR
$5.82B
$10.5M 0.05%
249,302
+16,925
+7% +$697K
ENR icon
358
Energizer
ENR
$1.47B
$10.4M 0.05%
351,745
+25,443
+8% +$769K
LCII icon
359
LCI Industries
LCII
$2.59B
$10.3M 0.05%
84,061
+5,745
+7% +$676K
STLD icon
360
Steel Dynamics
STLD
$36.2B
$10.3M 0.05%
69,374
+12,564
+22% +$1.58M
WST icon
361
West Pharmaceutical
WST
$23.7B
$10.2M 0.05%
25,819
+22,203
+614% +$8.21M
FFIV icon
362
F5
FFIV
$22B
$10.2M 0.05%
53,856
+46,317
+614% +$8.55M
YETI icon
363
Yeti Holdings
YETI
$3.87B
$10.2M 0.05%
263,954
+18,052
+7% +$763K
PWR icon
364
Quanta Services
PWR
$84.2B
$10.1M 0.05%
38,992
-2,410
-6% -$533K
PKG icon
365
Packaging Corp of America
PKG
$22.2B
$9.94M 0.05%
52,360
-5,166
-9% -$896K
ACWV icon
366
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.34B
$9.76M 0.05%
92,712
-4,703
-5% -$483K
IWN icon
367
iShares Russell 2000 Value ETF
IWN
$14.3B
$9.75M 0.05%
61,367
-2,972
-5% -$450K
AMD icon
368
Advanced Micro Devices
AMD
$700B
$9.61M 0.05%
53,265
-2,035
-4% -$356K
BNL icon
369
Broadstone Net Lease
BNL
$4.25B
$9.51M 0.05%
606,767
-52,413
-8% -$827K
IJS icon
370
iShares S&P Small-Cap 600 Value ETF
IJS
$8.12B
$9.37M 0.05%
91,156
-816
-0.9% -$81K
IWV icon
371
iShares Russell 3000 ETF
IWV
$19.2B
$9.13M 0.05%
30,424
-308
-1% -$87.9K
GWW icon
372
W.W. Grainger
GWW
$64.2B
$9M 0.05%
8,844
-361
-4% -$336K
NEOG icon
373
Neogen
NEOG
$2.05B
$8.96M 0.04%
567,800
+40,290
+8% +$675K
LXP icon
374
LXP Industrial Trust
LXP
$3.52B
$8.94M 0.04%
198,274
+14,315
+8% +$651K
IWR icon
375
iShares Russell Mid-Cap ETF
IWR
$55.9B
$8.89M 0.04%
105,684
+12,076
+13% +$957K

Similar funds

Glenmede Trust's Q1 2024 Portfolio in Review

As of Q1 2024, Glenmede Trust held 1,397 positions worth $19.9B, up 3.5% from $19.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Glenmede Trust withdrew a net $801M in Q1 2024, closing 56 positions and reducing 573 holdings. Its most notable exit was Under Armour, an estimated $13.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Dynatrace worth $47.1M.

  • Glenmede Trust's largest Q1 2024 buy was Dynatrace: 1,013,219 shares worth $47.1M.
  • Glenmede Trust added most to Qualcomm in Q1 2024, an estimated $38.4M increase.
  • Glenmede Trust's biggest Q1 2024 reduction was KLA, cutting an estimated $78.4M.
  • Glenmede Trust fully exited Under Armour in Q1 2024, selling an estimated $13.4M.
  • Glenmede Trust's ten largest holdings make up 23% of its $19.9B portfolio in Q1 2024.
  • Glenmede Trust opened 101 new positions and closed 56 in Q1 2024.
  • Glenmede Trust's portfolio value rose 3.5% quarter-over-quarter to $19.9B.

Based on Glenmede Trust's 13F filing for Q1 2024, filed 15 May 2024.